BridgeBio Oncology Therapeutics, Inc. (BBOT) › EPS (Diluted)BridgeBio Oncology Therapeutics, Inc. (BBOT) — EPS (Diluted)Annual figures by fiscal year, from SEC filings.2024: $-5756.412025: $-4.30$-4.302024EPS (Diluted) (USD/shares)2025Fiscal YearEPS (Diluted)Change YoY2025$-4.30+99.9%2024$-5756.41—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share